Literature DB >> 7693777

Infantile (juvenile) capillary hemangioma: a tumor of heterogeneous cellular elements.

B R Smoller1, D B Apfelberg.   

Abstract

Infantile (juvenile) capillary hemangiomas are vascular neoplasms which can appear quite infiltrative histologically and are characterized by cords of cells with areas of marked cellularity. While vessels can be distinguished in most cases, there are many cells which do not appear to be endothelial in origin. We labeled 5 such cases with antibodies directed against factor VIII-related antigen, CD34, alpha actin, factor XIIIa and PC-10. Anti-factor VIII-related antigen labeled all endothelial cells and did not label cells away from vessels. Anti-CD34 recognized similar cells and also stained a subset of interstitial cells. Anti-alpha muscle defined pericytes and stained few interstitial cells and none of the endothelial cells. Many of the interstitial spindled and cuboidal cells stained strongly with anti-factor XIIIa. The majority of the mitotic activity was concentrated in the interstitial cells. These observations lend support to the concept that infantile (juvenile) capillary hemangioma is a tumor of primitive cells with capabilities for differentiating toward endothelial cells and pericytes. It is not clear whether a similar stem cell population gives rise to dermal dendrocytes, or whether these represent an immune response to the neoplasm.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693777     DOI: 10.1111/j.1600-0560.1993.tb01271.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  12 in total

1.  Testicular capillary haemangioma in a child.

Authors:  G Atkin; M Miller; K S Clarkson; A J Molyneux
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation.

Authors:  Elisa Boscolo; Camille L Stewart; Shoshana Greenberger; June K Wu; Jennifer T Durham; Ira M Herman; John B Mulliken; Jan Kitajewski; Joyce Bischoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-14       Impact factor: 8.311

3.  Infantile hemangiomas: A review.

Authors:  Alison B Callahan; Michael K Yoon
Journal:  Saudi J Ophthalmol       Date:  2012-05-23

4.  Evidence by molecular profiling for a placental origin of infantile hemangioma.

Authors:  Carmen M Barnés; Sui Huang; Arja Kaipainen; Despina Sanoudou; Emy J Chen; Gabriel S Eichler; Yuchun Guo; Ying Yu; Donald E Ingber; John B Mulliken; Alan H Beggs; Judah Folkman; Steven J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

5.  Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells.

Authors:  Y Yu; J Varughese; L F Brown; J B Mulliken; J Bischoff
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.

Authors:  Shoshana Greenberger; Elisa Boscolo; Irit Adini; John B Mulliken; Joyce Bischoff
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

7.  Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1.

Authors:  Elisa Boscolo; John B Mulliken; Joyce Bischoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

8.  Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.

Authors:  Zia A Khan; Elisa Boscolo; Arnaud Picard; Sarah Psutka; Juan M Melero-Martin; Tatianna C Bartch; John B Mulliken; Joyce Bischoff
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 9.  Vasculogenesis in infantile hemangioma.

Authors:  Elisa Boscolo; Joyce Bischoff
Journal:  Angiogenesis       Date:  2009-05-10       Impact factor: 9.596

Review 10.  Pathogenesis of infantile haemangioma.

Authors:  S Greenberger; J Bischoff
Journal:  Br J Dermatol       Date:  2013-07       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.